Kinetics and determinants of the changes of CC16, a lung secretory protein in a rat model of toxic lung injury

References

• Hermans C, Bernard A. Pneumoproteinaemia: A new perspective in the assessment of lung disorders. Eur Respir J 1998; 11: 801–803
   PubMed Web of Science ®Google Scholar
• Singh G, Singh J, Katyal SL, Brown WE, Kramps JA, Paradis IL, Dauber JH, Macpherson TA, Squeglia N. Identification, cellular localization, isolation, and characterization of human Clara cell-specific 10 KD protein. J Histochem Cytochem 1988; 36: 73–80
   PubMed Web of Science ®Google Scholar
• Singh G, Katyal SL. An immunologic study of the secretory products of rat Clara cells. J Histochem Cytochem 1984; 32: 49–54
   PubMed Web of Science ®Google Scholar
• Bernard A, Marchandise FX, Depelchin S, Lauwerys R, Sibille Y. Clara cell protein in serum and bronchoalveolar lavage. Eur Respir J 1992; 5: 1231–1238
   PubMed Web of Science ®Google Scholar
• Shijubo N, Itoh Y, Yamaguchi T, Shibuya Y, Morita Y, Hirasawa M, Okutani R, Kawai T, Abe S. Serum and BAL Clara cell 10 kDa protein (CC10) levels and CC10-positive bronchiolar cells are decreased in smokers. Eur Respir J 1997; 10: 1108–1114
   PubMed Web of Science ®Google Scholar
• Halatek T, Hermans C, Broeckaert F, Wattiez R, Wiedig M, Toubeau G, Falmagne P, Bernard A. Quantification of Clara cell protein in rat and mouse biological fluids using a sensitive immunoassay. Eur Respir J 1998; 11: 726–733
   PubMed Web of Science ®Google Scholar
• Bernard A, Thielemans N, Lauwerys R, Vandeleene B, Lambert AE. The renal handling of protein 1 (Clara cell protein): effect of age, sex and renal dysfunction. Contrib Nephrol 1993; 101: 66–70
   PubMedGoogle Scholar
• Bernard A, Roels H, Buchet JP, Lauwerys R. Decrease of serum Clara cell protein in smokers [letter]. Lancet 1992; 339: 1620
   PubMed Web of Science ®Google Scholar
• Bernard AM, Roels HA, Buchet JP, Lauwerys RR. Serum Clara cell protein: An indicator of bronchial cell dysfunction caused by tobacco smoking. Environ Res 1994; 66: 96–104
   PubMed Web of Science ®Google Scholar
• Lumsden AB, McLean A, Lamb D. Goblet and Clara cells of human distal airways: Evidence for smoking induced changes in their numbers. Thorax 1984; 39: 844–849
   PubMed Web of Science ®Google Scholar
• Hermans C, Osman A, Nyberg BI, Peterson C, Bernard A. Determinants of Clara cell protein (CC16) concentration in serum: A reasessment with two different immunoassays. Clin Chim Acta 1998; 272: 101–110
   PubMed Web of Science ®Google Scholar
• Lesur O, Bernard A, Arsalane K, Lauwerys R, Begin R, Cantin A, Lane D. Clara cell protein (CC-16) induces a phospholipase A2-mediated inhibition of fibroblast migration in vitro. Am J Respir Crit Care Med 1995; 152: 290–297
   PubMed Web of Science ®Google Scholar
• Bernard A, Hermans C, Van Houte G. Transient increase of serum Clara cell protein (CC16) after exposure to smoke. Occup Environ Med 1997; 54: 63–65
   PubMed Web of Science ®Google Scholar
• Hermans C, Petrek M, Kolek V, Pieters T, Lambert M, Bernard A. Serum Clara cell protein (CC16) correlates with chest radiographic abnormalities of sarcoidosis. Am J Respir Crit Care Med 1997; 155: A981
   Google Scholar
• Kabanda A, Jadoul M, Pochet JM, Lauwerys R, van Ypersele de Strihou C, Bernard A. Determinants of the serum concentrations of low molecular weight proteins in patients on maintenance hemodialysis. Kidney Int 1994; 45: 1689–1696
   PubMed Web of Science ®Google Scholar
• Doster AR, Farrell RL, Wilson BJ. An ultrastructural study of bronchiolar lesions in rats induced by 4-ipomeanol, a product from mold-damaged sweet potatoes. Am J Pathol 1983; 111: 56–61
   PubMed Web of Science ®Google Scholar
• Sabo JP, Kimmel EC, Diamond L. Effects of the Clara cell toxin, 4‐ipomeanol, on pulmonary function in rats. J Appl Physiol 1983; 54: 337–344
   PubMed Web of Science ®Google Scholar
• Day BJ, Carlson GP, DeNicola D. B. gamma-Glutamyltranspeptidase in rat bronchoalveolar lavage fluid as a probe of 4-ipomeanol and alpha‐naphthylthiourea-induced pneumotoxicity. J Pharmacol Methods 1990; 24: 1–8
   PubMedGoogle Scholar
• Verschoyle RD, Philpot RM, Wolf CR, Dinsdale D. CYP4B1 activates 4-ipomeanol in rat lung. Toxicol Appl Pharmacol 1993; 123: 193–198
   PubMed Web of Science ®Google Scholar
• Newton PE, Latendresse JR, Mattie DR, Pfledderer C. Alterations in alveolar clearance after 4-ipomeanol-induced necrosis of Clara and ciliated cells in the terminal bronchiole of the rat. Toxicol Appl Pharmacol 1985; 80: 534–541
   PubMed Web of Science ®Google Scholar
• Boyd MR, Neal RA. Studies on the mechanism of toxicity and of development of tolerance to the pulmonary toxin, alpha-naphthylthiourea (ANTU). Drug Metab Dispos 1976; 4: 314–322
   PubMed Web of Science ®Google Scholar
• Cunningham AL, Hurley JV. Alpha-naphthyl-thiourea-induced pulmonary oedema in the rat: a topographical and electron-microscope study. J Pathol 1972; 106: 25–35
   PubMed Web of Science ®Google Scholar
• Viau C, Bernard A, Ouled A, Lauwerys R. Determination of rat beta 2‐microglobulin in urine and in serum. II. Application of its urinary measurement to selected nephrotoxicity models. J Appl Toxicol 1986; 6: 191–195
   PubMed Web of Science ®Google Scholar
• Girolami JP, Orfila C, Pecher C, Cabos Boutot G, Bascands JL, Moatti JP, Adam A, Colle A. Inverse relationship between renal and urinary kallikrein during chromate-induced acute renal failure in rat: Urinary kallikrein excretion as a possible recovery index. Biol Chem Hoppe Seyler 1989; 370: 1305–1313
   PubMed Web of Science ®Google Scholar
• Smith P, Heath D. Paraquat. CRC Crit Rev Toxicol 1976; 4: 411–445
   PubMed Web of Science ®Google Scholar
• Smith P, Heath D. The pathology of the lung in paraquat poisoning. J Clin Pathol Suppl R Coll Pathol 1975; 9: 81–93
   PubMedGoogle Scholar
• Smith P, Heath D. The ultrastructure and time sequence of the early stages of paraquat lung in rats. J Pathol 1974; 114: 177–184
   PubMed Web of Science ®Google Scholar
• Smith P, Heath D, Kay JM. The pathogenesis and structure of paraquat-induced pulmonary fibrosis in rats. J Pathol 1974; 114: 57–67
   PubMed Web of Science ®Google Scholar
• Hampson EC, Eyles DW, Pond SM. Effects of paraquat on canine bronchoalveolar lavage fluid. Toxicol Appl Pharmacol 1989; 98: 206–215
   PubMed Web of Science ®Google Scholar
• Abrahamson M, Olafsson I, Palsdottir A, Ulvsback M, Lundwall A, Jensson O, Grubb A. Structure and expression of the human cystatin C gene. Biochem J 1990; 268: 287–294
   PubMed Web of Science ®Google Scholar
• Bernard A, Lauwerys R, Noel A, Vandeleene B, Lambert A. Determination by latex immunoassay of protein 1 in normal and pathological urine. Clin Chim Acta 1991; 201: 231–245
   PubMed Web of Science ®Google Scholar
• Halatek T, Hermans C, Wattiez R, Wiedig M, Toubeau G, Falmagne P, Bernard A. Quantification of Clara cell protein in rat and mouse biological fluids using a sensitive immunoassay. Eur Respir J 1998; 11: 726–733
   PubMed Web of Science ®Google Scholar
• Jorens PG, Sibille Y, Goulding NJ, van Overveld FJ, Herman AG, Bossaert L, De Backer WA, Lauwerys R, Flower RJ, Bernard A. Potential role of Clara cell protein, an endogenous phospholipase A2 inhibitor, in acute lung injury. Eur Respir J 1995; 8: 1647–1653
   PubMed Web of Science ®Google Scholar
• Hermans C, Bernard A. Lung epithelium specific proteins : characteristics and potential applications as markers. State of the art. Am J Respir Crit Care Med 1999; 159: 646–678
   PubMed Web of Science ®Google Scholar
• Dierynck I, Bernard A, Roels H, De Ley M. Potent inhibition of both interferon-gamma production and biologic activity by the Clara cell protein CC16. Am J Respir Cell Mol Biol 1995; 12: 205–210
   PubMed Web of Science ®Google Scholar
• Guy J, Dhanireddy R, Mukherjee AB. Surfactant-producing rabbit pulmonary alveolar type II cells synthetize and secrete an antiinflammatory protein, uteroglobulin. Biochem Biophys Res Commun 1992; 189: 662–669
   PubMed Web of Science ®Google Scholar
• Bernard A, Dumont X, Roels H, Lauwerys R, Dierynck I, De Ley M, Stroobant V, de Hoffmann E. The molecular mass and concentrations of protein 1 or Clara cell protein in biological fluids: a reappraisal. Clin Chim Acta 1993; 223: 189–191
   PubMed Web of Science ®Google Scholar
• Itoh Y, Ishii S, Okutani R, Asano Y, Kawai T. Protein 1: Its purification and application in clinical medicine. J Clin Lab Anal 1993; 7: 394–400
   PubMed Web of Science ®Google Scholar
• Shijubo N, Itoh Y, Yamaguchi T, Shibuya Y, Morita Y, Hirasawa M, Okutani R, Kawai T, Abe S. Serum and BAL Clara cell 10 kDa protein (CC10) levels and CC10-positive bronchiolar cells are decreased in smokers. Eur Respir J 1997; 10: 1108–1114
   PubMed Web of Science ®Google Scholar
• Lesur O, Bernard A, Arsalane K, Lauwerys R, Begin R, Cantin A, Lane D. Clara cell protein (CC16) induces a phospholipase A2-mediated inhibition of fibroblast migration in vitro. Am J Respir Crit Care Med 1995; 152: 290–297
   PubMed Web of Science ®Google Scholar
• Jorens PG, Sibille Y, Goulding NJ, van Overveld FJ, Herman AG, Bossaert L, De Backer WA, Lauwerys R, Flower RJ, Bernard A. Potential role of Clara cell protein, an endogenous phospholipase A2 inhibitor, in acute lung injury. Eur Respir J 1995; 8: 1647–1653
   PubMed Web of Science ®Google Scholar
• Lesur O, Langevin S, Berthiaume Y, Legare M, Skrobik Y, Bellemare JF, Levy B, Fortier Y, Lauzier F, Bravo G, Nickmilder M, Rousseau E, Bernard A, Critical Care Research Group of the Quebec Respiratory Health Network. Outcome value of Clara cell protein in serum of patients with acute respiratory distress syndrome. Intensive Care Med 2006; 32: 1167–1174
   PubMed Web of Science ®Google Scholar
• Hermans C, Knoops B, Wiedig M, Arsalane K, Toubeau G, Falmagne P, Bernard A. Clara cell protein (CC16) in experimental lung injury: assessment as marker of Clara cell damage and bronchoalveolar blood barrier permeability. Eur Respir J 1999; 13: 1014–1021
   PubMed Web of Science ®Google Scholar
• Hantson P, Weynand B, Doyle I, Bernard A, Hermans C. Pneumoproteins as markers of paraquat kung injury: A clinical case. J Legl Forensic Med 2008; 15: 48–52
   PubMedGoogle Scholar
• Bell DY, Haseman JA, Spock A, McLennan G, Hook GE. Plasma proteins of the bronchoalveolar surface of the lungs of smokers and nonsmokers. Am Rev Respir Dis 1981; 124: 72–79
   PubMed Web of Science ®Google Scholar
• Jones KP, Edwards JH, Reynolds SP, Peters TJ, Davies BH. A comparison of albumin and urea as reference markers in bronchoalveolar lavage fluid from patients with interstitial lung disease. Eur Respir J 1990; 3: 152–156
   PubMed Web of Science ®Google Scholar
• Taylor AE, Gaar KAJ. Estimation of equivalent pore radii of pulmonary capillary and alveolar membranes. Am J Physiol 1970; 218: 1133–1140
   PubMed Web of Science ®Google Scholar
• Conhaim RL, Eaton A, Staub NC, Heath TD. Equivalent pore estimate for the alveolar-airway barrier in isolated dog lung. J Appl Physiol 1988; 64: 1134–1142
   PubMed Web of Science ®Google Scholar
• Holter JF, Weiland JE, Pacht ER, Gadek JE, Davis WB. Protein permeability in the adult respiratory distress syndrome. Loss of size selectivity of the alveolar epithelium. J Clin Invest 1986; 78: 1513–1522
   PubMed Web of Science ®Google Scholar
• Doyle IR, Hermans C, Bernard A, Nicholas TE, Bersten AD. Clearance of Clara cell secretory protein and surfactant proteins A and B from blood in acute respiratory failure. Am J Respir Crit Care Med 1999; 158: 1528–1535
   Web of Science ®Google Scholar
• Kabanda A, Goffin E, Bernard A, Lauwerys R, van Ypersele de Strihou C. Factors influencing serum levels and peritoneal clearances of low molecular weight proteins in continuous ambulatory peritoneal dialysis. Kidney Int 1995; 48: 1946–1952
   PubMed Web of Science ®Google Scholar
• Hermans C, Dong P, Robin M, Jadoul M, Bernard A, Bersten AD, Doyle IR. Determinants of serum levels of surfactant proteins A and B and Clara cell protein CC16. Biomarkers 2003; 8: 461–471
   PubMed Web of Science ®Google Scholar